More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$173997975
EPS
-1.59
P/E ratio
--
Price to sales
0.55
Dividend yield
--
Beta
1.728573
Previous close
$2.56
Today's open
$2.56
Day's range
$2.44 - $2.62
52 week range
$2.02 - $8.50
show more
CEO
Daniel Burton
Employees
728
Headquarters
South Jordan, UT
Exchange
Nasdaq Global Select
Shares outstanding
70730884
Issue type
Common Stock
Healthcare
Healthcare Providers & Services
Matt Arens, CEO and Founder of Health Catalyst's Largest Shareholder, First Light Asset Management, Joins Board of Directors
SALT LAKE CITY , Dec. 2, 2025 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst" or the "Company," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Matt Arens, CEO and Founder of First Light Asset Management, LLC ("First Light"), has been appointed to serve as a member of Health Catalyst's board of directors ("Board"), effective Dec. 1, 2025. A shareholder since Health Catalyst's IPO in 2019, First Light is the Company's largest shareholder, and First Light and Mr.
PRNewsWire • Dec 2, 2025

Health Catalyst to Participate in Upcoming Investor Conferences
SALT LAKE CITY, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that members of senior management will participate in the following upcoming investor conferences: The Stephens Annual Investment Conference, being held in Nashville, including a fireside chat with Ben Albert, President and Chief Operating Officer, Jason Alger, Chief Financial Officer, and Matt Hopper, SVP of Finance and Head of Investor Relations, on Wednesday, November 19, 2025 at 3:00pm CT. The Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum, being held in New York, including 1x1 meeting opportunities with Dan Burton, Chief Executive Officer, Ben Albert, President and Chief Operating Officer, Jason Alger, Chief Financial Officer, and Matt Hopper, SVP of Finance and Head of Investor Relations, on Thursday, November 20, 2025.
GlobeNewsWire • Nov 14, 2025

Health Catalyst, Inc. (HCAT) Q3 2025 Earnings Call Transcript
Health Catalyst, Inc. ( HCAT ) Q3 2025 Earnings Call November 10, 2025 5:00 PM EST Company Participants Matt Hopper Daniel Burton - CEO & Director Benjamin Albert - President & COO Jason Alger - Chief Financial Officer Conference Call Participants Jared Haase - William Blair & Company L.L.C., Research Division Jessica Tassan - Piper Sandler & Co., Research Division Elizabeth Anderson - Evercore ISI Institutional Equities, Research Division Richard Close - Canaccord Genuity Corp., Research Division Daniel Grosslight - Citigroup Inc., Research Division David Larsen - BTIG, LLC, Research Division Stanislav Berenshteyn - Wells Fargo Securities, LLC, Research Division Jeffrey Garro - Stephens Inc., Research Division Gabrielle Ingoglia - Cantor Fitzgerald & Co., Research Division Presentation Operator Welcome to the Health Catalyst Third Quarter 2025 Earnings Conference Call.
Seeking Alpha • Nov 11, 2025

Health Catalyst Reports Third Quarter 2025 Results
SALT LAKE CITY, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (“Health Catalyst,” Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter ended September 30, 2025. “For the third quarter of 2025, I am pleased by our financial results, including total revenue of $76.3 million and Adjusted EBITDA of $12.0 million, with these results beating our quarterly guidance on each measure,” said Dan Burton, CEO of Health Catalyst.
GlobeNewsWire • Nov 10, 2025

Health Catalyst (HCAT) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
The headline numbers for Health Catalyst (HCAT) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Zacks Investment Research • Nov 11, 2025

Health Catalyst (HCAT) Q3 Earnings and Revenues Top Estimates
Health Catalyst (HCAT) came out with quarterly earnings of $0.06 per share, beating the Zacks Consensus Estimate of $0.05 per share. This compares to earnings of $0.07 per share a year ago.
Zacks Investment Research • Nov 11, 2025

Health Catalyst Achieves HITRUST r2 Certification, Demonstrating the Highest Level of Information Protection Assurance
SALT LAKE CITY , Nov. 10, 2025 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Twistle by Health Catalyst (Twistle), Lumeon by Health Catalyst (Lumeon), and Upfront by Health Catalyst (Upfront) have earned certified status by HITRUST for information security. HITRUST r2 Certification demonstrates that Twistle, Lumeon, and Upfront have met demanding regulatory compliance and industry-defined requirements that assess whether offerings are appropriately managing risk.
PRNewsWire • Nov 10, 2025

UnityPoint Health to Unlock Next Phase of Analytics Innovation by Activating Health Catalyst Ignite™
SALT LAKE CITY , Nov. 10, 2025 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that UnityPoint Health, an integrated non-profit health system that provides care throughout Iowa, western Illinois and southern Wisconsin in not-for-profit hospitals, clinics, and home health settings, is set to migrate from Health Catalyst's legacy data platform to its modern data platform, Health Catalyst Ignite™ Data and Analytics. Since beginning their partnership in 2016, UnityPoint Health has realized meaningful and measurable improvements through Health Catalyst's legacy data and analytics platform.
PRNewsWire • Nov 10, 2025

Health Catalyst (HCAT) Q3 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
Besides Wall Street's top-and-bottom-line estimates for Health Catalyst (HCAT), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2025.
Zacks Investment Research • Nov 6, 2025

Impax Small Cap Fund Q3 2025 Contributors And Detractors
Ligand Pharmaceuticals (LGND) (Health Care, Pharmaceuticals) shares rose after announcing adjusted earnings per share that came in ahead of consensus. Acadian Asset Management (AAMI) (Financials, Asset Management & Custody Banks) saw another quarter of better-than-expected flows, driving earnings upside relative to expectations. SI-Bone (SIBN) (Health Care, Health Care Equipment) was weaker despite reporting a marginal beat on revenue and expectations of improved profitability.
Seeking Alpha • Oct 28, 2025

¹ Disclosures

Open an M1 investment account to buy and sell Health Catalyst Inc commission-free¹. Build wealth for the long term using automated trading and transfers.